A method of identifying a 5'AMP-activated protein kinase inhibitor for treating a neurodegenerative disease. Disclosed are a method and a packaged product for treating a neurodegenerative disease. Also disclosed is a method for treating a 5'AMP-activated protein kinase-related disease and a related packaged product.